Does the AstraZeneca vaccine still pass the risk-benefit analysis for young people?

Sky News

07 Apr 2021 0 shares 1 views

Sky News

Published 07 Apr 2021

The greater the risk of a disease, the greater the risk doctors would be prepared to take to prevent it.

Full Article

Moderna vaccine 'may be reserved for young people' amid AstraZeneca risk

The EMA and the MHRA have both carried out reviews into reports of rare brain clots in people who have had the AstraZeneca vaccine

Tamworth Herald 07 Apr 2021

Younger adults are most at risk of rare blood clotting after having the Oxford-AstraZeneca vaccine, the UK’s medicines regulator..

The Argus 30 Apr 2021